SILO PHARMA, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SILO PHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $250.00K.
- SILO PHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2021-03-31 was $83.73K.
- SILO PHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2019-09-30 was $8.75K.
- SILO PHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2019-06-30 was $8.75K.
- SILO PHARMA, INC. stock issued during period, value, issued for services for fiscal 2022 was $135.10K, a 61.36% increase from fiscal 2021.
- SILO PHARMA, INC. stock issued during period, value, issued for services for fiscal 2021 was $83.73K.
- SILO PHARMA, INC. stock issued during period, value, issued for services for fiscal 2019 was $35.00K.
- SILO PHARMA, INC. stock issued during period, value, issued for services for fiscal 2013 was $2.00M.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-03-31 | $250.00K 10-Q · filed 2026-08-13 | |
| 2022-12-31 | $135.10K 10-K · filed 2024-03-25 | |
| 2021-12-31 | $83.73K 10-K · filed 2023-03-24 | |
| 2021-03-31 | $83.73K 10-Q · filed 2022-11-10 | |
| 2019-12-31 | $35.00K 10-K/A · filed 2021-05-17 | |
| 2019-09-30 | $8.75K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $8.75K 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $8.75K 10-Q · filed 2020-11-05 | |
| 2013-12-31 | $2.00M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |